Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
61 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Burden and Treatment of Achondroplasia: A Systematic Literature Review.
Murton MC, Drane ELA, Goff-Leggett DM, et al. · Adv Ther · 2023Systematic Review, Research Support, Non-U.S. Gov't
- Once-Weekly Navepegritide in Children With Achondroplasia: The APPROACH Randomized Clinical Trial.
Savarirayan R, McDonnell C, Bacino CA, et al. · JAMA Pediatr · 2026Randomized Controlled Trial, Multicenter Study
- Achondroplasia: Really rhizomelic?
Shelmerdine SC, Brittain H, Arthurs OJ, et al. · Am J Med Genet A · 2016Meta-Analysis, Research Support, Non-U.S. Gov't
- Real-world outcomes of vosoritide in achondroplasia: A systematic review and meta-analysis of multinational clinical evidence.
Albuquerque ALB, Dacoregio MI, Rodrigues CG, et al. · Genet Med · 2026Systematic Review, Meta-Analysis
- Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial.
Savarirayan R, Tofts L, Irving M, et al. · Lancet · 2020Clinical Trial, Phase III, Multicenter Study
- Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study.
Savarirayan R, Tofts L, Irving M, et al. · Genet Med · 2021Clinical Trial, Phase III, Randomized Controlled Trial
- Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial.
Savarirayan R, Wilcox WR, Harmatz P, et al. · Lancet Child Adolesc Health · 2024Clinical Trial, Phase II, Multicenter Study
- Sustained growth-promoting effects of vosoritide in children with achondroplasia from an ongoing phase 3 extension study.
Savarirayan R, Irving M, Wilcox WR, et al. · Med · 2025Clinical Trial, Phase III, Randomized Controlled Trial
- Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.
Savarirayan R, Hoover-Fong J, Irving M, et al. · N Engl J Med · 2026Randomized Controlled Trial, Multicenter Study
- Oral Infigratinib Therapy in Children with Achondroplasia.
Savarirayan R, De Bergua JM, Arundel P, et al. · N Engl J Med · 2025Multicenter Study, Clinical Trial, Phase II
- [Syringomyelia in children].
Zérah M · Neurochirurgie · 1999Clinical Trial, English Abstract
- Birth prevalence of achondroplasia: A systematic literature review and meta-analysis.
Foreman PK, van Kessel F, van Hoorn R, et al. · Am J Med Genet A · 2020Meta-Analysis, Research Support, Non-U.S. Gov't
- Persistent growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health-related quality of life.
Savarirayan R, Irving M, Wilcox WR, et al. · Genet Med · 2024Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Growth hormone therapy in achondroplasia.
Seino Y, Yamanaka Y, Shinohara M, et al. · Horm Res · 2000Clinical Trial, Randomized Controlled Trial
- Impact of paternal age on assisted reproductive technology outcomes and offspring health: a systematic review.
Gourinat A, Mazeaud C, Hubert J, et al. · Andrology · 2023Systematic Review
- Growth hormone therapy in achondroplasia.
Nishi Y, Kajiyama M, Miyagawa S, et al. · Acta Endocrinol (Copenh) · 1993Clinical Trial
- Progress report: growth hormone in skeletal dysplasia.
Bridges NA, Brook CG · Horm Res · 1994Clinical Trial, Review
- Craniofacial syndromes and class III phenotype: common genotype fingerprints? A scoping review and meta-analysis.
Faria-Teixeira MC, Tordera C, Salvado E Silva F, et al. · Pediatr Res · 2024Meta-Analysis, Scoping Review
- Molecular and Genetic Mechanisms of Spinal Stenosis Formation: Systematic Review.
Byvaltsev VA, Kalinin AA, Hernandez PA, et al. · Int J Mol Sci · 2022Systematic Review
- Impact of achondroplasia on Latin American patients: a systematic review and meta-analysis of observational studies.
Fano V, Kim CA, Rosselli P, et al. · Orphanet J Rare Dis · 2022Meta-Analysis, Research Support, Non-U.S. Gov't
- A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia.
Dauber A, Savarirayan R, Campeau PM, et al. · NEJM Evid · 2026Clinical Trial, Phase III, Randomized Controlled Trial
- Molecular, phenotypic aspects and therapeutic horizons of rare genetic bone disorders.
Faruqi T, Dhawan N, Bahl J, et al. · Biomed Res Int · 2014Systematic Review
- Efficacy and safety of Vosoritide in achondroplasia: A systematic review and meta-analysis.
Pahuja M, Prakash C, Umrao A, et al. · Indian J Med Res · 2026Systematic Review, Meta-Analysis
- C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia.
Savarirayan R, Irving M, Bacino CA, et al. · N Engl J Med · 2019Clinical Trial, Phase II, Multicenter Study
- Pharmacokinetics and Exposure-Response of Vosoritide in Children with Achondroplasia.
Chan ML, Qi Y, Larimore K, et al. · Clin Pharmacokinet · 2022Clinical Trial, Phase II, Clinical Trial, Phase III
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.